news

FEBRUARY 12, 2025

Kenai Therapeutics Establishes Research Facility at Lilly Gateway Labs


NOVEMBER 14, 2024

Kenai Therapeutics Establishes Patient Advisory Board


OCTOBER 23, 2024

Kenai Therapeutics Announces the Appointment of Dr. Derek Hei as Chief Technology Officer


FEBRUARY 29, 2024

Kenai Therapeutics Announces $82 Million Series A Financing to Advance Next Generation Allogeneic Cell Therapies for Neurological Diseases